We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
51
PTC Therapeutics
PTCT
$6.33B
$39.3M 0.41%
773,960
+171,970
+29% +$8.45M
PDD icon
52
Pinduoduo
PDD
$120B
$39.2M 0.41%
456,800
+148,200
+48% +$8.92M
TSLA icon
53
Tesla
TSLA
$1.22T
$39.1M 0.41%
543,465
-452,475
-45% -$24.5M
HOLX
54
DELISTED
Hologic
HOLX
$38.4M 0.4%
672,998
+317,739
+89% +$15.6M
KMB icon
55
Kimberly-Clark
KMB
$37B
$37.4M 0.39%
264,247
+121,816
+86% +$16.8M
AMAT icon
56
Applied Materials
AMAT
$412B
$36.9M 0.39%
609,702
+242,115
+66% +$13.1M
XOM icon
57
ExxonMobil
XOM
$641B
$36.5M 0.38%
815,065
+315,474
+63% +$14.1M
C icon
58
Citigroup
C
$223B
$36.3M 0.38%
711,242
-103,578
-13% -$4.91M
XLRN
59
DELISTED
Acceleron Pharma
XLRN
$36.3M 0.38%
381,009
-101,549
-21% -$9.79M
APD icon
60
Air Products & Chemicals
APD
$65.4B
$35.9M 0.38%
148,767
+59,640
+67% +$13.6M
HD icon
61
Home Depot
HD
$336B
$35.7M 0.38%
142,680
-60,147
-30% -$13.8M
LH icon
62
Labcorp
LH
$24.6B
$34.5M 0.36%
241,785
+105,844
+78% +$14.6M
QCOM icon
63
Qualcomm
QCOM
$179B
$34.5M 0.36%
378,004
-176,184
-32% -$14.1M
VIPS icon
64
Vipshop
VIPS
$7.08B
$34.1M 0.36%
1,714,000
-291,000
-15% -$5M
DRNA
65
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$34.1M 0.36%
1,343,269
+463,769
+53% +$9.99M
ORCL icon
66
Oracle
ORCL
$346B
$33.8M 0.36%
611,795
+60,826
+11% +$3.22M
ALL icon
67
Allstate
ALL
$67.1B
$33.5M 0.35%
345,350
+24,824
+8% +$2.44M
INCY icon
68
Incyte
INCY
$23.8B
$33.3M 0.35%
320,566
+30,545
+11% +$2.94M
NEE icon
69
NextEra Energy
NEE
$185B
$32.3M 0.34%
537,728
+222,516
+71% +$13.3M
VZ icon
70
Verizon
VZ
$197B
$32.2M 0.34%
583,592
-233,024
-29% -$13.1M
ADSW
71
DELISTED
Advanced Disposal Services Inc
ADSW
$31.6M 0.33%
1,047,755
+332,800
+47% +$10.6M
ONC
72
BeOne Medicines Ltd
ONC
$34B
$31.3M 0.33%
166,276
+40,779
+32% +$6.64M
UNP icon
73
Union Pacific
UNP
$177B
$31.1M 0.33%
183,764
-9,625
-5% -$1.54M
TGTX icon
74
TG Therapeutics
TGTX
$8.64B
$30.1M 0.32%
1,547,071
+587,098
+61% +$9.46M
NFLX icon
75
Netflix
NFLX
$294B
$30M 0.32%
659,040
+161,180
+32% +$6.86M
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.